The invention relates inter alia to a compound of general formula (I) or (I'): wherein X is -CO-R 1 or -SO 2 -R 2 , R 1 is an alkyl, haloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl or alkylamino radical of 4 to 20 carbon atoms (for example of 5 to 20 carbon atoms, of 8 to 20 carbon atoms, of 9 to 20 carbon atoms, of 10 to 18 carbon atoms, of 12 to 18 carbon atoms, of 13 to 18 carbon atoms, of 14 to 18 carbon atoms, of 13 to 17 carbon atoms.)； and R 2 is an alkyl radical of 4 to 20 carbon atoms (for example of 5 to 20 carbon atoms, of 8 to 20 carbon atoms, of 9 to 20 carbon atoms, of 10 to 18 carbon atoms, of 12 to 18 carbon atoms, of 13 to 18 carbon atoms, of 14 to 18 carbon atoms, and of 13 to 17 carbon atoms)； or alternatively R 1 and R 2 are selected independently from a peptido radical having from 1 to 4 peptidic moieties linked together by peptide bonds.본 발명은 염증 질환을 예방 또는 치료하기 위해 의도된 약제를 제조하기 위한 3-아미노카프로락탐 유도체의 용도에 관한 것이고, 일반식 (Ⅰ) 또는 약제학적으로 허용가능한 그것의 염을 사용한다； 여기서 X는 -CO-R1 또는 -SO2-R2이고, R1 및 R2는 탄소포함 치환체이다.
